First Gene Therapy Kymriah (tisagenlecleucel) Approved in U.S.
WEDNESDAY, Aug. 30, 2017 -- The U.S. Food and Drug Administration on Wednesday approved the first gene therapy in the United States, to treat children and young adults with a particularly tough type of leukemia.
Kymriah (tisagenlecleucel) is for...
Source: Drugs.com - Daily MedNews - Category: General Medicine Source Type: news
More News: Children | Food and Drug Administration (FDA) | Gene Therapy | General Medicine | Genetics | Leukemia | USA Health